📊 Isomorphic Labs Unveiled: Google’s $3B AI Drug Discovery Play—Your Insider Edge to a 10x Biotech Boom Before It Explodes

Your Weekly Shortcut to Deeptech Investing — Trends, Startup Intel & Investor Playbooks for VCs & Angels in 5 Minutes or Less

Today I’m diving deep into Isomorphic Labs—a startup that’s got my attention as Google’s big swing at AI-driven drug discovery. Founded by Demis Hassabis, the genius behind DeepMind’s AlphaFold, this company’s riding a wave of Nobel Prize-winning tech and a massive $600 million raise that’s pushed its valuation toward $3 billion. I’ve pieced together the cap table, sized up their technical edge against competitors, and thought through a big downside risk: what if AlphaFold 3 flops or gets outdone? Here’s everything I’ve uncovered—let’s get into it!